|
2023 Conference Publication Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracersLim, Ting Xiang, Migotto, Mary-Anne, Mardon, Karine, Paterson, Brett and Reutens, David (2023). Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracers. International Symposium on Radiopharmaceutical Sciences iSRS 2023, Honolulu, HI, United States, 22-26 May 2023. Philadelphia, PA, United States: Elsevier. |
|
2023 Conference Publication Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracersLim, Ting Xiang, Migotto, Mary-anne, Mardon, Karine, Paterson, Brett and Reutens, David (2023). Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracers. International Symposium on Radiopharmaceutical Sciences iSRS 2023, Honolulu, HI USA, 22-26 May 2023. Philadelphia, PA USA: Elsevier. doi: 10.1016/j.nucmedbio.2023.108619 |
|
2016 Conference Publication First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET)Hicks, Rodney, Jackson, Price, Ware, Robert, Drummond, Elizabeth, Roselt, Peter, Noonan, Wayne, Price, Roger, Jeffrey, Charmaine, Callahan, Jason, Hong, Emily, Hicks, Lauren, Hedt, Amos, Paterson, Brett, Kong, Grace and Donnelly, Paul (2016). First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET). RESTON: SOC NUCLEAR MEDICINE INC. |
